Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-100
Closed -$22.4K – 315
2026
Q1
$22.4K Hold
100
– – 0.02% 246
2025
Q4
$24.1K Hold
100
– – 0.02% 258
2025
Q3
$27.4K Hold
100
– – 0.02% 256
2025
Q2
$25.8K Buy
+100
New +$23.9K 0.02% 252
2024
Q3
$24.4K Hold
100
– – 0.02% 231
2024
Q2
$19.1K Buy
+100
New +$20.3K 0.02% 247
2023
Q3
$29.6K Hold
200
– – 0.03% 210
2023
Q2
$43.7K Buy
+200
New +$44.6K 0.04% 181
2023
Q1
– Sell
-250
Closed -$52K – 344
2022
Q4
$52K Buy
+250
New +$54.9K 0.04% 188
2022
Q3
– Sell
-250
Closed -$52K – 328
2022
Q2
$52K Buy
+250
New +$53.2K 0.04% 158
2021
Q1
– Sell
-250
Closed -$212K – 120
2020
Q4
$212K Buy
+250
New +$49.8K 0.06% 51

Other funds holding RMD

WFA of San Diego's RMD Position: Q2 2026 in Review

WFA of San Diego sold out of ResMed (RMD) in Q2 2026, closing a stake of 100 shares — an estimated $22.4K sold.

WFA of San Diego first reported a position in RMD in Q4 2020 and held it in 11 quarters. The position peaked at $212K in Q4 2020. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • WFA of San Diego reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • WFA of San Diego sold 100 ResMed shares in Q2 2026, an estimated $22.4K.
  • WFA of San Diego first reported a position in ResMed in Q4 2020 and held it in 11 quarters.
  • WFA of San Diego's ResMed position peaked at $212K in Q4 2020.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on WFA of San Diego's 13F filing for Q2 2026, filed 14 Aug 2026.